Diaceutics PLC
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 USD
−2.13 M USD
40.23 M USD
51.38 M
About Diaceutics Plc
Sector
Industry
CEO
Ryan Gerard Keeling
Website
Headquarters
Belfast
Founded
2005
IPO date
Mar 21, 2019
Identifiers
2
ISIN GB00BJQTGV64
Diaceutics Plc engages in the provision of data, data analytics and implementation services. It also provides insights generated from its testing data from its worldwide laboratory network to pharmaceutical companies. The company was founded in 2005 and is headquartered in Belfast, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DIUXF is 1.67 USD — it has increased by 22.15% in the past 24 hours. Watch Diaceutics PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Diaceutics PLC stocks are traded under the ticker DIUXF.
We've gathered analysts' opinions on Diaceutics PLC future price: according to them, DIUXF price has a max estimate of 3.28 USD and a min estimate of 2.50 USD. Watch DIUXF chart and read a more detailed Diaceutics PLC stock forecast: see what analysts think of Diaceutics PLC and suggest that you do with its stocks.
DIUXF reached its all-time high on Jan 15, 2026 with the price of 2.51 USD, and its all-time low was 1.05 USD and was reached on Jul 5, 2023. View more price dynamics on DIUXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DIUXF stock is 68.43% volatile and has beta coefficient of 1.05. Track Diaceutics PLC stock price on the chart and check out the list of the most volatile stocks — is Diaceutics PLC there?
Today Diaceutics PLC has the market capitalization of 191.79 M, it has decreased by −0.67% over the last week.
Yes, you can track Diaceutics PLC financials in yearly and quarterly reports right on TradingView.
Diaceutics PLC is going to release the next earnings report on Sep 29, 2026. Keep track of upcoming events with our Earnings Calendar.
DIUXF net income for the last half-year is −3.30 M USD, while the previous report showed 1.10 M USD of net income which accounts for −399.04% change. Track more Diaceutics PLC financial stats to get the full picture.
No, DIUXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 199 employees. See our rating of the largest employees — is Diaceutics PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Diaceutics PLC EBITDA is 3.88 M USD, and current EBITDA margin is 7.25%. See more stats in Diaceutics PLC financial statements.
Like other stocks, DIUXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Diaceutics PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Diaceutics PLC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Diaceutics PLC stock shows the strong buy signal. See more of Diaceutics PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.